Plasma Therapy Market Likely to Emerge over a Period of 2020 - 2029: BioLife Plasma Services, Grifols International S.A., Biotest, CSL Ltd.

Plasma Therapy Market Snapshot:

The plasma therapy market was valued at USD 205.15 million in 2019 and is expected to grow with a CAGR of 14.8%.

Plasma therapy aims at using antibodies from the blood to treat chronic, life-threatening conditions. In the last few years, plasma therapy has proven to be an effective treatment in terms of improving life expectancies and survival rates. Increasing incidences of accidental blood loss and rising healthcare expenditure provide an impetus the market growth. Plasma therapy is emerging as a standard practice, and a number of healthcare professionals are actively adopting the therapy to treat the growing list of orthopedic and other therapeutic conditions. The FDA has recently approved the use of plasma therapy on COVID-19 patients.

Globally, the healthcare sectors are channelizing efforts to manufacture plasma-derived medicinal products using albumin, coagulation factors, and immunoglobulin, to treat several chronic and acute life-threatening diseases. Several of these products are included in the Essential Medicines Lists of the World Health Organization.

Rising approval of plasma therapies, increasing R&D activities, and burgeoning demand for advanced therapeutics drive the market growth. In 2016 around 74% of sourced plasma came from the U.S.  Plasma therapy is also used in replacement therapies to treat deficiency of coagulation factors in autoimmune disorders. Immunoglobulin holds one of the largest shares of about 40–50% (about USD 20 billion) in the plasma therapy market. On the other hand, albumin and plasma-derived factor VIII each hold a significant market share of about 10–15% each.

The plasma therapy market’s most prominent driver is the emergence of new indications such as immune deficiencies and immune-mediated diseases. Today, prominent market players are continuously working to develop innovative plasma-derived medicinal products for the treatment of several neurological disorders such as neuropathic pain, myasthenia gravis, and post-polio syndrome. Plasma-derived albumin is under clinical trial for the treatment of liver diseases, malaria, sepsis, and Alzheimer’s diseases. Additionally, the rising use of immunoglobulin as a treatment is projected to bolster market growth. In the U.S., approximately USD 40,000 is invested in subcutaneous Immunoglobulin treatment for severe immune deficiencies.
The pure platelet-rich plasma segment held the largest market share owing to its widespread applications in cosmetics, general, cardiovascular, and wound healing surgeries. Pure platelet-rich plasma therapy aids in soft tissue healing, regeneration of ligament and tendon fibers, and reduces the risk of the post and preoperative bleeding. Hence, it is considered as one of the most significant treatment methods for the management of several chronic diseases.

North America leads the plasma therapy market on account of the rising application of plasma therapy in therapeutics and an increasing number of people suffering from orthopedic injuries. The regional market is also backed by the presence of leading players, well-established healthcare infrastructure, favorable regulatory framework, and government support.  As per the Centers for Disease Control and Prevention (CDC), in the U.S., about 54.4 million people were diagnosed with joint arthritis, rheumatoid arthritis, and gout in between 2013—2015, of which around 22% of the patient’s opted for plasma therapy.

The autologous segment is projected to hold the largest market share as it eliminates the cost of clinical analysis for blood-borne diseases and has a low threat of disease transmission compared to allogenic. On the other hand, the allogenic plasma source is collected from the donor’s blood using aphaeresis technology, further prompting the need for stringent donor selection and testing criteria.

Obtain Brochure For Latest Technology Advancements @ 
https://straitsresearch.com/report/plasma-therapy-market/request-sample

The Major Prominent Players Covered in this Report:
BioLife Plasma Services
Grifols International S.A.
Biotest, CSL Ltd.
Cambryn Biologics LLC
Bio Products Laboratory Ltd.
China Biologic Products, Inc.
Kedrion S.p.A.
Octapharma
LFB biopharmaceutical

By Type- Pure platelet-rich plasma (PRP), Leukocyte-rich PRP, Pure platelet-rich fibrin (PRF), Leukocyte-rich fibrin (L-PRF), Plasma proteins
By Source- Autologous, Allogenic
By Application- Orthopedic, Chronic infectious diseases, Dermatology, Dental, Cardiac muscle Injury, Nerve injury
By End-User- Hospitals and clinics, Research institutions

Growing Domestic Demand and Expanding Pharmaceutical Sector to Drive the Demand for Plasma Therapy in the APAC Region
Asia-Pacific region is anticipated to hold the largest market share in the global Plasma Therapy market during the forecast period 2019-2029. The growth in this region can be attributed to the presence of emerging economies like India, China, Japan, Vietnam, and Indonesia, which account for the largest share in this region. India is one of the largest producers of Plasma Therapy and a major exporter of the product to various countries across the globe. India accounts for around 80% of the world’s exports of Plasma Therapy. The favorable climatic conditions and growth of agricultural inputs and allied services like cold storage and warehousing in India are prompting higher production.

View this report with a detailed description and TOC @ 
https://straitsresearch.com/report/plasma-therapy-market/toc

Impact of COVID 19:
Currently, the world is battling the newly emerged strain, coronavirus, which has no definitive treatment. A similar picture of lack of definitive therapy can be traced in the history of medical science during the Ebola outbreak, where the World Health Organization (WHO) directed the use of convalescent plasma (CP) therapy to control its prevalence. Today, plasma therapy is used as one of the methods to treat COVID 19 patients. Recently, the U.S. FDA approved the use of plasma therapy for critically ill COVID-19 patients, further driving the market growth. 

Key Questions Answered in The Report:
What will the Plasma Therapy market growth rate?
What are the key factors driving the global Plasma Therapy market?
Who are the key manufacturers in the Plasma Therapy market space?
What are the market opportunities, market risk, and market overview of the Plasma Therapy market?
What are sales, revenue, and price analysis of top manufacturers of the Plasma Therapy market?
Who are the distributors, traders, and dealers of the Plasma Therapy market?
What are the market opportunities and threats faced by the vendors in the global Steerable Medical Devices Industry?
What are sales, revenue, and price analysis by types and applications of the Plasma Therapy Industry?
What are sales, revenue, and price analysis by regions of Plasma Therapy industry?
What are the driving factors contributing to market growth during the short, medium, and long term?

Key Plasma Therapy Market Trends:
- The report identifies, determines, and forecasts the Global Plasma Therapy Market segments based on their type, sub-type, technology used, applications, end-users, and regions.
- Industry to Industry Holds Largest Share in the Plasma Therapy Market
- It examines the micro-markets based on their growth trends, development patterns, future prospects, and contribution to the overall market.
- Demand from Regional / geographical is Expected to Drive the Growth
- Rising Adoption of Market Segments in this Growth
- North American, Europe is Expected to Witness Higher Growth Rate over the Forecast Period
- It studies the competitive developments such as partnerships and collaborations, mergers and acquisitions (M&A), research and development (R&D) activities, product developments, and expansions in the Global Plasma Therapy Market.

Browse Full Report @ 
https://straitsresearch.com/report/plasma-therapy-market/

Even if your business is a multinational venture or a single storefront, we believe innovation is the key to progress, in both what you build and how you promote your products and brands.

Buy Full Report with Detail Analysis with COVID-19 Impact – https://straitsresearch.com/buy-now/plasma-therapy-market/global/

So let's put our minds together. We'll make your vision a reality and help you grow.

For more details, please contact us -
Straits Research
Email: sales@straitsresearch.com
Address: 825 3rd Avenue, New York, NY 10022
Tel: +1 646 480 7505, +44 208 068 9665
Website: https://straitsresearch.com/

About Us:
Regardless of whether you're looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with what customers purchase. We overcome the issues of our customers by recognizing and deciphering just the target group, while simultaneously generating leads with the highest precision. We seek to collaborate with our customers to deliver a broad spectrum of results through a blend of market and business research approaches. This approach of using various research and analysis strategies enables us to determine greater insights by eliminating the research costs.

This release was published on openPR.